A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a randomized, double-blind placebo-controlled multicenter phase 3 trial to evaluate the efficacy and safety of ARGX-113 in patients with primary ITP.
Epistemonikos ID: 2d1c0bacc79db4c0c79dc48b47cfe1510b9f187b
First added on: May 07, 2024